Characterization of human serum dipeptidyl peptidase IV (CD26) and analysis of its autoantibodies in patients with rheumatoid arthritis and other autoimmune diseases.
about
Dipeptidyl peptidase IV activity and/or structure homologs: contributing factors in the pathogenesis of rheumatoid arthritis?Circulating CD26 is negatively associated with inflammation in human and experimental arthritis.Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease.Rhinorrhea, cough and fatigue in patients taking sitagliptinStreptokinase promotes development of dipeptidyl peptidase IV (CD26) autoantibodies after fibrinolytic therapy in myocardial infarction patients.Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer.Autoantibodies against cell surface GRP78 promote tumor growth in a murine model of melanomaPotential of soluble CD26 as a serum marker for colorectal cancer detection.CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis.Intraindividual changes of dipeptidyl peptidase-IV in peripheral blood of patients with rheumatoid arthritis are associated with the disease activity.Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.DPP-4 Inhibitor-Induced Rheumatoid Arthritis Among Diabetics: A Nested Case-Control Study.Improved glycaemia in high-fat-fed neprilysin-deficient mice is associated with reduced DPP-4 activity and increased active GLP-1 levels.Circulating fibroblast activation protein and dipeptidyl peptidase 4 in rheumatoid arthritis and systemic sclerosis.Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands.
P2860
Q24813111-6AE65B60-326F-458F-976A-C87667314B03Q31144845-D35C3E17-70A7-41E3-A5B4-696D46B23A3EQ33711704-D056D15D-561F-4076-8732-BE2E00CA92FCQ33878740-BB5BCDB6-7F4E-4AC1-9610-DB82BA738D6FQ34175049-8125813D-CC66-4FD9-B005-58CF84BE2B31Q34468372-B93C3B49-657C-44DF-868A-2D8EB7116EECQ35048279-2FCD65F8-1665-45E9-B6DD-6E8CC790B4F5Q35113393-9DB55F15-5EA0-4C2F-9E99-20A0C5D6D625Q35692539-66290D33-F2B6-4F69-89C9-C353EAEDA141Q35768486-6A826616-D70E-4B3B-9FD2-09A245695D22Q38751579-47304115-AFE2-479A-B8A4-441A50EC0012Q47318130-70C1C7B5-B4A3-43FA-A8A8-9628D64A23A8Q48017526-4B71376C-FEC6-4E70-9A97-66D81F426115Q48141620-3485846D-C458-4A28-B768-A036AFFC6429Q49524220-37774392-F4C4-4E84-9C45-55F61B1209B9
P2860
Characterization of human serum dipeptidyl peptidase IV (CD26) and analysis of its autoantibodies in patients with rheumatoid arthritis and other autoimmune diseases.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Characterization of human seru ...... and other autoimmune diseases.
@en
Characterization of human serum dipeptidyl peptidase IV
@nl
type
label
Characterization of human seru ...... and other autoimmune diseases.
@en
Characterization of human serum dipeptidyl peptidase IV
@nl
prefLabel
Characterization of human seru ...... and other autoimmune diseases.
@en
Characterization of human serum dipeptidyl peptidase IV
@nl
P2093
P1476
Characterization of human seru ...... and other autoimmune diseases.
@en
P2093
M Cuchacovich
M Gonzalez-Gronow
P304
P577
2001-11-01T00:00:00Z